Altimmune, Inc. (ALT)
3.065
-0.19
(-5.84%)
USD |
NASDAQ |
May 07, 11:52
Altimmune Free Cash Flow : -67.55M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Eli Lilly & Co. | 10.37B |
| Amgen, Inc. | 8.597B |
| Madrigal Pharmaceuticals, Inc. | -275.41M |
| CorMedix, Inc. | 172.79M |
| Viking Therapeutics, Inc. | -340.33M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -19.15M |
| Cash from Investing (Quarterly) | -79.16M |
| Cash from Financing (Quarterly) | 80.83M |
| Free Cash Flow Per Share (Quarterly) | -0.1903 |
| Free Cash Flow to Equity (Quarterly) | -38.93M |
| Free Cash Flow to Firm (Quarterly) | -18.28M |
| Free Cash Flow Yield | -25.40% |